Skip to main content
Search Button
Estados Unidos Tienda Kobo Tarjetas de regalo Ayuda

Kobo Rakuten

Wishlist

Carrito de compra

¡Obtienes el tratamiento VIP!

Artículos no disponibles para compra.
Por favor revisa tu carrito. Puedes eliminar los artículos no disponibles ahora o los eliminaremos nosotros automáticamente al momento de pagar.
artículosartículo
artículosartículo

Recomendado para ti

Loading...


Serie m´´as popular en Estados Unidos

1 - 12 de 12 resultados para “kevin grimes”
Skip side bar filters

  • A Practical Guide to Drug Development in Academia

    The SPARK Approach

    Edición de Daria Mochly-Rosen, Kevin Grimes ...
    Series series Medicine (R0)
    "A lot of hard-won knowledge is laid out here in a brief but informative way. Every topic is well referenced, with citations from both the primary literature and relevant resources from the internet." Review of first edition from Nature Chemical BiologyWritten by the founders of the SPARK program at Stanford University, this book is a practical guide designed for professors, students and ... Leer más

    $49.99 USD

  • 學界藥品開發實用指南──SPARK方法論

    A Practical Guide to Drug Development in Academia: The SPARK Approach

    de Daria Mochly-Rosen, Kevin Grimes, Steven R. Alexander, Mark Backer, Rebecca Begley, Terrence Blaschke, Peter Boyd, Jennifer Swanton Brown, Liliane Brunner Halbach0, Leon Chen1, Eugenio L. de Hostos2, Emily Egeler3, Daniel Erlanson4, Nicholas Gaich5, Harry Greenberg6, Scott Iyama7, Carol Karp8, Kevin Kinsella9, Bruce Koch0, Katharine Ku1, Robert Lum2, Ted McCluskey3, Alan Mendelson4, Judy Mohr5, Julie Papanek6, Christopher M. Reilly7, Werner Rubas8, Steven Schow9, Michael Taylor0, Simeon Taylor1, Stephen Venuto2, Susan Wade3, John Walker4 ...
    Traducido por 曾宇鳳5 ...
    Series series 教科書
    《學界藥品開發實用指南：SPARK方法論》並非是一本教讀者「如何製藥」的操作手冊，而是集結「史丹佛大學SPARK計畫」十餘年來的轉譯研究產學實務，試圖闢出一條「扭轉學界思維、活用業界實務」的藥品研發之路。「SPARK計畫」的特色在於匯集化學、生物學、藥理學、毒理學、醫學、法規科學、統計學、創投、商業等各領域專家擔任業師群，讓學界研究人員與業界專家得以在研發過程持續交流學習，進而提高轉譯成功率。關於SPARK Taiwan計畫臺灣自2012年導入美國史丹佛大學「Stanford SPARK計畫」，並由科技部生命科學發展司與國家實驗研究院科技政策研究與資訊中心共同成立「SPARK Taiwan 計畫」並推動「生醫與醫材轉譯加值人才培訓計畫」。此計畫希望借鏡史丹佛大學的成功經驗，協助臺灣學術研究機構建立校內輔導轉譯商品化機制、同時培育生醫產業人才，以期縮短學術研發成果與業界商品開發之間的落差 ... Leer más

    $15.99 USD

  • A Practical Guide to Drug Development in Academia

    The SPARK Approach

    Edición de Daria Mochly-Rosen, Kevin Grimes ...
    Series series Medicine (R0)
    "A lot of hard-won knowledge is laid out here in a brief but informative way. Every topic is well referenced, with citations from both the primary literature and relevant resources from the internet." Review from Nature Chemical BiologyWritten by the founders of the SPARK program at Stanford University, this book is a practical guide designed for professors, students and clinicians at academic ... Leer más

    $71.99 USD

La gente que leyó estos también disfrutó

  • Malignant

    How Bad Policy and Bad Evidence Harm People with Cancer

    de Vinayak K. Prasad ...
    How hype, money, and bias can mislead the public into thinking that many worthless or unproven treatments are effective.Each week, people read about new and exciting cancer drugs. Some of these drugs are truly transformative, offering major improvements in how long patients live or how they feel—but what is often missing from the popular narrative is that, far too often, these new drugs have ... Leer más

    $29.99 USD

  • Real World Drug Discovery

    A Chemist's Guide to Biotech and Pharmaceutical Research

    de Robert M. Rydzewski ...
    Drug discovery increasingly requires a common understanding by researchers of the many and diverse factors that go into the making of new medicines. The scientist entering the field will immediately face important issues for which his education may not have prepared him: project teams, patent law, consultants, target product profiles, industry trends, Gantt charts, target validation, ... Leer más

    $80.99 USD

  • Pharmaceutical Lifecycle Management

    Making the Most of Each and Every Brand

    de Tony Ellery, Neal Hansen ...
    A comprehensive guide to optimizing the lifecycle management of pharmaceutical brandsThe mounting challenges posed by cost containment policies and the prevalence of generic alternatives make optimizing the lifecycle management (LCM) of brand drugs essential for pharmaceutical companies looking to maximize the value of their products. Demonstrating how different measures can be combined to create ... Leer más

    $88.00 USD

  • Early Drug Development

    Strategies and Routes to First-in-Human Trials

    Edición de Mitchell N. Cayen ...
    The focus of early drug development has been the submission of an Investigational New Drug application to regulatory agencies. Early Drug Development: Strategies and Routes to First-in-Human Trials guides drug development organizations in preparing and submitting an Investigational New Drug (IND) application. By explaining the nuts and bolts of preclinical development activities and their ... Leer más

    $161.00 USD

  • The Future of Drug Discovery

    Who Decides Which Diseases to Treat?

    de Tamas Bartfai, Graham V. Lees ...
    The Future of Drug Discovery: Who decides which diseases to treat? provides a timely and detailed look at the efforts of the pharmaceutical industry and how they relate, or should relate, to societal needs. The authors posit that as a result of increasing risk aversion and accelerated savings in research and development, the industry is not developing drugs for increasingly prevalent diseases, ... Leer más

    $40.99 USD

  • Fast Facts: Biosimilars in Hematology and Oncology

    Biologics and biosimilars - getting decisions right

    de Paul Cornes, Ali McBride ...
    Biologics have revolutionized – and are revolutionizing – the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical experience, with more than 50 biosimilar drugs and more than 700 million patient-days' exposure in Europe, shows that approved biosimilars can be used as safely and effectively as originator biologics. Yet concerns persist about biosimilars – ... Leer más

    Gratis

  • Global New Drug Development

    An Introduction

    de Jan A. Rosier, Mark A. Martens, Josse R. Thomas ...
    Series series ULLA Series in Pharmaceutical Sciences
    The development of new drugs is very complex, costly and risky. Its success is highly dependent on an intense collaboration and interaction between many departments within the drug development organization, external investigators and service providers, in constant dialogue with regulatory authorities, payers, academic experts, clinicians and patient organizations. Within the different phases of ... Leer más

    $110.00 USD

  • A Clinical Trials Manual From The Duke Clinical Research Institute

    Lessons from a Horse Named Jim

    de Margaret Liu, Kate Davis ...
    "The publication of the second edition of this manual comes at an important juncture in the history of clinical research. As advances in information technology make it possible to link individuals and groups in diverse locations in jointly seeking the answers to pressing global health problems, it is critically important to remain vigilant about moral and ethical safeguards for every patient ... Leer más

    $80.00 USD

  • Principles and Practice of Pharmaceutical Medicine

    Edición de Lionel D. Edwards, Anthony W. Fox, Peter D. Stonier ...
    The new edition of Principles and Practice of Pharmaceutical Medicine is a comprehensive reference guide to all aspects of pharmaceutical medicine. New content includes chapters and coverage on regulatory updates, increasing international harmonization, transitional and probabilistic approaches to drug development, the growing sophistication and regulatory importance of pharmacovigilance, ... Leer más

    $300.00 USD